Expanding the clinicopathological spectrum of late cutaneous Lyme borreliosis (acrodermatitis chronica atrophicans [ACA]): A prospective study of 20 culture- and/or polymerase chain reaction (PCR)-documented cases.

Date publication

avril 2016

Journal

Journal of the American Academy of Dermatology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr CRIBIER Bernard , Dr GRANEL-BROCARD Florence , Pr LIPSKER Dan

Tous les auteurs :
Lenormand C, Jaulhac B, Debarbieux S, Dupin N, Granel-Brocard F, Adamski H, Barthel C, Cribier B, Lipsker D

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/26781226

Résumé

The diagnosis of acrodermatitis chronica atrophicans (ACA), the late cutaneous manifestation of Lyme borreliosis, can be challenging. Histologic changes in ACA have been described in a few studies from endemic countries, relying on cases documented by serology only.

Mots clés

Acrodermatitis, diagnosis, Adult, Age Distribution, Aged, Aged, 80 and over, Biopsy, Needle, Borrelia burgdorferi, isolation & purification, Cohort Studies, DNA, Bacterial, analysis, Erythema Chronicum Migrans, diagnosis, Female, France, epidemiology, Humans, Immunohistochemistry, Incidence, Lyme Disease, diagnosis, Male, Middle Aged, Polymerase Chain Reaction, methods, Prognosis, Prospective Studies, Risk Assessment, Severity of Illness Index, Sex Distribution

Référence

J. Am. Acad. Dermatol.. 2016 Apr;74(4):685-92